Delivery Order SPE2DB22D2206-SPE2DB25FJW29
Award Date 9/10/25
Potential Completion Date 10/1/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on April 24, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Onivyde is a specialized oncology medication used in cancer treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials on September 4, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price delivery order represents a non-competitive procurement awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials valued at $5,345.67 with a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by July 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials, with a firm fixed price ceiling value of $10,691.34 and an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,127.56 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,691.34 delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 mL vials on June 5, 2025, with completion targeted for June 27, 2025. ONIVYDE (irinotecan liposome injection) is a chemotherapy agent used in cancer treatment, reflecting the breadth of pharmaceutical products supplied through federal medical procurement channels. This non-competitive delivery order is priced on a firm fixed-price basis and will be performed at the vendor's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,461.90 delivery order contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $3,563.78 delivery order from the Defense Logistics Agency (DLA) on April 22, 2025, for ONIVYDE 43 mg/10 mL vials. This firm fixed-price contract, with an ultimate completion date of May 13, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $10,112.40. This delivery order contract has a completion date of February 15, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, is the sole...